Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients

  • Masiá, Mar
  • Padilla, Sergio
  • Fernández, Marta
  • Moreno, Ana
  • Oteo, José A
  • Antela, Antonio
  • Moreno, Santiago
  • Amo, Julia del
  • Gutiérrez, Félix
  • Rodriguez-Blazquez, Carmen
OBJECTIVE: We aimed to assess whether oxidative stress is a predictor of mortality in HIV-infected patients. METHODS: We conducted a nested case-control study in CoRIS, a contemporary, multicentre cohort of HIV-infected patients, antiretroviral-naïve at entry, launched in 2004. Cases were patients who died with available stored plasma samples collected. Two age and sex-matched controls for each case were selected. We measured F2-isoprostanes (F2-IsoPs) and malondialdehyde (MDA) plasma levels in the first blood sample obtained after cohort engagement. RESULTS: 54 cases and 93 controls were included. Median F2-IsoPs and MDA levels were significantly higher in cases than in controls. When adjustment was performed for age, HIV-transmission category, CD4 cell count and HIV viral load at cohort entry, and subclinical inflammation measured with highly-sensitive C-reactive protein (hsCRP), the association of F2-IsoPs with mortality remained significant (adjusted OR per 1 log10 increase, 2.34 [1.23-4.47], P = 0.009). The association of MDA with mortality was attenuated after adjustment: adjusted OR (95% CI) per 1 log10 increase, 2.05 [0.91-4.59], P = 0.080. Median hsCRP was also higher in cases, and it also proved to be an independent predictor of mortality in the adjusted analysis: OR (95% CI) per 1 log10 increase, 1.39 (1.01-1.91), P = 0.043; and OR (95% CI) per 1 log10 increase, 1.46 (1.07-1.99), P = 0.014, respectively, when adjustment included F2-IsoPs and MDA. CONCLUSION: Oxidative stress is a predictor of all-cause mortality in HIV-infected patients. For plasma F2-IsoPs, this association is independent of HIV-related factors and subclinical inflammation.
Repisalud
Publication Artículo científico (JournalArticle)

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

  • Restrepo, Clara
  • Gutiirrez-Rivas, Monica
  • Pacheco, Yolanda María
  • García, Marcial
  • Blanco, Julià
  • Medrano, Luz Maria
  • Navarrete-Muñoz, María A
  • Gutiérrez, Félix
  • Miralles, Pilar
  • Dalmau, David
  • Gómez, Juan Luis
  • Górgolas, Miguel
  • Cabello, Alfonso
  • Resino, Salvador
  • Benito, José Miguel
  • Rallón, Norma
OBJECTIVE: We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. METHODS: A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/μL and successful viral control for two years. CD4 count increase below 200 cells/μL after two years on cART was used to define INR (immunological non-responder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. RESULTS: Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL12 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). CONCLUSIONS: CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Contrast sensitivity in multimodal large language models: A psychophysics-inspired evaluation

  • Hernández-Cámara, Pablo
  • Gomez-Villa, Alexandra
  • Jaén-Lorites, José Manuel
  • Vila-Tomás, Jorge
  • Laparra, Valero
  • Malo, Jesús
[EN] Understanding how Multimodal Large Language Models (MLLMs) process low-level visual features is critical for evaluating their perceptual abilities and has not been systematically characterized. Inspired by human psychophysics, we introduce a behavioural method for estimating the Contrast Sensitivity Function (CSF) in MLLMs by treating them as end-to-end observers. Models are queried with structured prompts while viewing noise-based stimuli filtered at specific spatial frequencies. Psychometric functions are derived from the binary verbal responses. Therefore, contrast thresholds (and CSFs) are obtained without relying on internal activations or classifier-based proxies, as opposed to previous reports on artificial networks. Our results reveal that some models resemble human CSFs in shape or scale, but none capture both. We also find that CSF estimates are highly sensitive to prompt phrasing, indicating limited linguistic robustness. Finally, we show that CSFs predict model performance under frequency-filtered and adversarial conditions. These findings highlight systematic differences in frequency tuning across MLLMs and establish this CSF estimation as a scalable diagnostic tool for multimodal perception., This work was supported in part by MICIIN/FEDER/UE under Grant PID2023-152133NB-I00; in part by Spanish MIU under Grant FPU21/02256; in part by Generalitat Valenciana under Project GV/2021/074, CIPROM/2021/056; and in part by the grant BBVA Foundations of Science program: Maths, Stats, Comp. Sci. and AI (VIS4NN) . The authors gratefully acknowledge the computer resources at Artemisa and the technical support provided by the European Union through the 2014-2020 ERDF Operative Programme of Comunitat Valenciana, project IDIFEDER/2018/048.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia, a CRuCIAL study

  • García Martín, Paloma|||0000-0001-5582-8575
  • Moñiz Díez, Ana|||0000-0002-3260-9553
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • ter Horst, Rob|||0000-0003-0576-5873
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Macauda, Angelica|||0000-0001-9820-5079
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Hernández-Mohedo, Francisca
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • González-Sierra, Pedro Antonio|||0000-0002-6492-1728
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Puiggros, Anna|||0000-0001-9627-4978
  • Cerhan, James|||0000-0002-7482-178X
  • Marasca, Roberto|||0000-0002-6431-6878
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu|||0000-0001-5969-8640
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Morros, Rosa|||0000-0001-6752-8748
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María|||0000-0001-8864-1168
  • Llorca, Javier|||0000-0001-8569-861X
  • Jerez, Andrés|||0000-0002-2079-6638
  • Berndt, Sonja
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Casabonne, Delphine
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Campa, Daniele|||0000-0003-3220-9944
  • Canzian, Federico|||0000-0002-4261-4583
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Försti, Asta|||0000-0002-9857-4728
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Jurado, Manuel|||0000-0001-9156-3797
  • Sainz, Juan|||0000-0002-9355-2423
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy

  • Rodríguez-Gallego, Esther|||0000-0002-6363-2510
  • Gómez, Josep|||0000-0002-0573-7621
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Ferrando-Martínez, Sara
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • López-Dupla, Miguel
  • Beltrán-Debón, Raúl|||0000-0001-9691-1906
  • Alba, Verónica|||0000-0002-5925-9573
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Castellano, Alfonso J.
  • Leal, Manuel
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Vidal, Francesc|||0000-0002-6692-6186
  • Rull, Anna|||0000-0002-8907-7754
Dyslipidemia in HIV-infected patients is unique and pathophysiologically associated with host factors, HIV itself and the use of antiretroviral therapy (ART). The use of nuclear magnetic resonance spectroscopy (NMR) provides additional data to conventional lipid measurements concerning the number of lipoprotein subclasses and particle sizes. To investigate the ability of lipoprotein profile, we used a circulating metabolomic approach in a cohort of 103 ART-naive HIV-infected patients, who were initiating non-nucleoside analogue transcriptase inhibitor (NNRTI)-based ART, and we subsequently followed up these patients for 36 months. Univariate and multivariate analyses were performed to evaluate the predictive power of NMR spectroscopy. VLDL-metabolism (including VLDL lipid concentrations, sizes, and particle numbers), total triglycerides and lactate levels resulted in good classifiers of dyslipidemia (AUC 0.903). Total particles/HDL-P ratio was significantly higher in ART-associated dyslipidemia compared to ART-normolipidemia (p = 0.001). Large VLDL-Ps were positively associated with both LDL-triglycerides (ρ 0.682, p < 0.001) and lactate concentrations (ρ 0.416, p < 0.001), the last one a marker of mitochondrial low oxidative capacity. Our data suggest that circulating metabolites have better predictive values for HIV/ART-related dyslipidemia onset than do the biochemical markers associated with conventional lipid measurements. NMR identifies changes in VLDL-P, lactate and LDL-TG as potential clinical markers of baseline HIV-dyslipidemia predisposition. Differences in circulating metabolomics, especially differences in particle size, are indicators of important derangements of mitochondrial function that are linked to ART-related dyslipidemia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

  • Masiá, Mar|||0000-0001-9878-2458
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Moreno, Santiago|||0000-0002-2843-1094
  • Barber, Xavier|||0000-0003-3079-5855
  • Iribarren, Jose A.
  • Del Romero, Jorge
  • Gómez-Sirvent, Juan L.
  • Rivero, María
  • Vidal, Francesc|||0000-0002-6692-6186
  • Campins, Antonio A.
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Del Amo, Julia|||0000-0002-3104-540X
  • Dalmau, David|||0000-0003-1936-478X
  • Navarro, Maria Luisa
  • González, Maria Isabel
  • Soriano, Vicente|||0000-0002-4624-5199
  • Garcia, Federico
  • Rubio, Rafael
  • Iribarren, José Antonio
  • Hernández, Beatriz
  • Berenguer, Juan|||0000-0001-8541-8200
  • Sobrino, Paz
  • Hernando, Victoria
  • Alejos, Belén
  • Álvarez, Débora
  • Monge, Susana|||0000-0003-1412-3012
  • Jarrín, Inma|||0000-0002-7485-2252
  • Rivero, Yaiza
  • González, Cristina
  • Muñoz-Fernández, M.Ängeles
  • García-Merino, Isabel
  • Rico, Coral Gómez
  • de la Fuente, Jorge Gallego
  • Torre, Almudena García
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Merino, Esperanza
  • Reus, Sergio|||0000-0002-3320-9754
  • Boix, Vicente|||0000-0002-7015-3948
  • Giner, Livia|||0000-0002-1885-3736
  • Gadea, Carmen
  • Portilla, Irene
  • Pampliega, Maria
  • Díez, Marcos
  • Rodríguez, Juan Carlos
  • Sánchez Payá, José
  • Podzamczer, Daniel|||0000-0001-7090-3561
  • Imaz, Arkaitz|||0000-0001-8411-1952
  • Van Den Eyncle, Evan
  • Di Yacovo, Silvana
  • Sumoy, Maria
  • Gómez, Juan Luis
  • Rodríguez, Patricia
  • Alemán, María Remedios
  • del Mar Alonso, María
  • Hernández, María Inmaculada
  • Díaz-Flores, Felicitas
  • García, Dácil
  • Pelazas, Ricardo
  • Labarga, Pablo
  • Barreiro, Pablo|||0000-0002-3819-5371
  • Rivas, Pablo
  • Blanco, Francisco
  • Carbonero, Luz Martín
  • Vispo, Eugenia
  • Solera, Carmen
  • Asensi, Víctor
  • Valle, Eulalia
  • Cartón, José Antonio
  • Pérez, Vicente Estrada
  • Molina, María Jesús Téllez
  • García, Jorge Vergas
  • Carrera, Elisa Pérez-Cecilia
  • Pulido, Federico|||0000-0002-7414-8812
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Matarranz, Mariano
  • Lagarde, Maria
  • Rubio-Martín, Rafael
  • Hernando, Asunción|||0000-0002-1901-1119
  • Portillo, Angel
  • Arrizabalaga, Julio
  • Aramburu, María José
  • Camino, Xabier
  • Rodríguez-Arrondo, Francisco
  • Von Wichmann, Miguel Ángel
  • Tomé, Lidia Pascual
  • Goenaga, Miguel Ángel
  • Bustinduy, M.J.
  • Galparsoro, H.A.
  • Ibarguren, M.
  • Aguado, Mirian
  • Masiá, M.
  • Fernández, Marta
  • García, Elena
  • Navarro, Andrés
  • Montolio, Fernando
  • Robledano, C.
  • Colomé, J.G.
  • Adsuar, Araceli
  • Pascual, R.
  • Muga, Roberto|||0000-0001-6301-431X
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • López Bernaldo de Quirós, Juan Carlos|||0000-0002-8989-9758
  • Miralles, Pilar
  • Gutiérrez, Isabel
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Padilla Ortega, Belén
  • Gijon, Paloma|||0000-0002-5011-1927
  • Carrero, Ana
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Parras, Francisco José
  • Balsalobre, Pascual
  • Diez, Cristina
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso, S.
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • López-Dupla, M.
  • Olona, Montserrat|||0000-0001-5303-9361
  • Aguilar, Alba
  • Sirvent, J.J.
  • Alba, Verónica|||0000-0002-5925-9573
  • Calavia, O.
  • Montero, M.
  • Lacruz, José
  • Blanes, M.
  • Calabuig, Eva|||0000-0002-0177-0037
  • Cuellar, S.
  • López, J.
  • Salavert, Miguel|||0000-0002-8571-2124
  • González García, Juan|||0000-0002-3652-002X
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Arribas, Jose|||0000-0002-7410-9450
  • Montes, María Luisa|||0000-0003-1748-813X
  • Peña, Jose M.
  • Arribas, Blanca
  • Castro, Juan Miguel
  • Zamora, Francisco
  • Pérez, I.
  • Estébanez, Miriam
  • García Bujalance, Silvia
  • Díaz, Marta
  • Alcáriz, Natalia Stella
  • Mingorance, Jesús|||0000-0001-6173-5711
  • Montero, Dolores
  • González Baeza, Alicia
  • José, Maria Isabel de
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • Sanz Sanz, Jesús
  • Salas, A.
  • Sarriá, C.
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Oteo, José A.|||0000-0001-7080-6542
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Ibarra, V.
  • Metola, L.
  • Sanz, M.
  • Pérez-Martínez, L.
  • Pascual, A.
  • Ramos, C.
  • Arazo, P.
  • Gil, D.
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Casado, M.I.
  • Díaz, J.A.
  • Uriz, J.
  • Repáraz, J.
  • Irigoyen, C.
  • Arraiza, M.J.
  • Segura, Ferrán
  • Amengual Guedan, Maria Jose|||0000-0002-5385-3061
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Sala, Montserrat
  • Cervantes Garcia, Manuel|||0000-0001-6073-1110
  • Pineda, Valentí
  • Segura, Victor
  • Navarro Vilasaro, Marta|||0000-0002-3784-4405
  • Antón, Esperanza
  • Nogueras, Maria-Mercedes|||0000-0001-5925-1929
  • Casado, José Luis|||0000-0002-7639-8591
  • Dronda, Fernando|||0000-0002-0443-5816
  • Moreno, Ana
  • Pérez Elías, Mª Jesus|||0000-0001-5700-5257
  • López, D.
  • Gutiérrez, Carolina
  • Madrid, N.
  • Lamas, A.
  • Martí, P.
  • De Diaz, A.
  • Serrrano, S.
  • Donat, Lucas
  • Cano, Amanda|||0000-0001-9567-4283
  • Bernal, Enrique|||0000-0002-4041-0579
  • Muñoz, Á.
  • García, F.
  • Hernández Quero, José
  • Peña, Alejandro
  • Muñoz Medina, Leopoldo|||0000-0001-8995-8271
  • Parra, J.
  • Alvarez, Mar|||0000-0003-4590-4401
  • Chueca, Natalia|||0000-0002-3420-3290
  • Guillot, V.
  • Vinuesa, David|||0000-0002-5663-8447
  • Fernández, J.A.
  • Rodríguez, Carmen
  • Puerta, T.
  • Carrió, J.C.
  • Vera, M.
  • Ballesteros, J.
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Sambeat, Maria Antonia
  • Lamarca, Karuna|||0000-0001-5292-2216
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Fernández-Duran, Irene|||0000-0003-1289-7276
  • Antela, A.
  • Losada, E.
  • Riera, M.
  • Peñaranda, María|||0000-0001-6290-3457
  • Leyes, M.
  • Ribas, M.A.
  • Campins, A.A.
  • Vidal, Carmen|||0000-0003-2768-2710
  • Gil, L.
  • Fanjul, F.
  • Marinescu, C.
  • Ribera, Esteban|||0000-0002-3752-8808
  • Santos, J.
  • Márquez, M.
  • Viciana, I.
  • Palacios, Rosario
  • González, C.M.
  • Viciana, P.
  • Leal, Manuel
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Trastoy, M.
  • Espinosa, Nuria|||0000-0003-2249-2352
Outcomes of people living with HIV (PLWH) developing non-AIDS events (NAEs) remain poorly defined. We aimed to classify NAEs according to severity, and to describe clinical outcomes and prognostic factors after NAE occurrence using data from CoRIS, a large Spanish HIV cohort from 2004 to 2013. Prospective multicenter cohort study. Using a multistate approach we estimated 3 transition probabilities: from alive and NAE-free to alive and NAE-experienced ("NAE development"); from alive and NAE-experienced to death ("Death after NAE"); and from alive and NAE-free to death ("Death without NAE"). We analyzed the effect of different covariates, including demographic, immunologic and virologic data, on death or NAE development, based on estimates of hazard ratios (HR). We focused on the transition "Death after NAE". 8,789 PLWH were followed-up until death, cohort censoring or loss to follow-up. 792 first incident NAEs occurred in 9.01% PLWH (incidence rate 28.76; 95% confidence interval [CI], 26.80-30.84, per 1000 patient-years). 112 (14.14%) NAE-experienced PLWH and 240 (2.73%) NAE-free PLWH died. Adjusted HR for the transition "Death after NAE" was 12.1 (95%CI, 4.90-29.89). There was a graded increase in the adjusted HRs for mortality according to NAE severity category: HR (95%CI), 4.02 (2.45-6.57) for intermediate-severity; and 9.85 (5.45-17.81) for serious NAEs compared to low-severity NAEs. Male sex (HR 2.04; 95% CI, 1.11-3.84), age.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • ter Horst, Rob|||0000-0003-0576-5873
  • Macauda, Angelica|||0000-0001-9820-5079
  • García Martín, Paloma|||0000-0001-5582-8575
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Pérez, Eva María
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Cerhan, James R.
  • Marasca, Roberto|||0000-0002-6431-6878
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu Hua
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Campa, Daniele|||0000-0003-3220-9944
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • de Sanjosé, Silvia
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María Flor
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Jerez, Andrés|||0000-0002-2079-6638
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Berndt, Sonja
  • Casabonne, Delphine
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Puiggros, Anna|||0000-0001-9627-4978
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Försti, Asta|||0000-0002-9857-4728
  • Canzian, Federico|||0000-0002-4261-4583
  • Sainz, Juan|||0000-0002-9355-2423
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients.